To model tumors with low mutational burden, we employed oncogene-driven cell lines that were derived from spontaneous tumors in transgenic mice, namely the Ret melanoma cell line (17) and the MYCN-amplified neuroblastoma cell line 9464D. Here, MYCN is linked to neuroblastoma.